Stada’s Consumer Healthcare business grew more than twice as fast as the global OTC market in 2023 as sales increased across all regions.
The Bad Vilbel, Germany-based firm reported CHC sales up 16% to €1.49bn ($1.62bn) over the 12 months, outpacing a non-prescription...